JAK/STAT Signaling

Various ligands including cytokines (e.g. interferons and interleukins), hormones (e.g. erythropoietin and growth hormone) and their cell surface receptors activate JAK proteins, which autophosphorylate, and then phosphorylate the receptor. Subsequently, JAKs phosphorylate a specific tyrosine residue on the STAT protein, promoting dimerization via SH2 domains. The activated STATs form homo-/heterodimers and translocate to the nucleus to trigger target gene transcription. In addition, suppressors of cytokine signaling (SOCS) family inhibit receptor signaling via homologous or heterologous feedback regulation. Dysregulation in JAK/STAT signaling is associated with diseases such as atherosclerosis, immunodeficiencies and cancer.
-   A3741 Pyridone 6Target: JAKSummary: Pan-JAK inhibitor A3741 Pyridone 6Target: JAKSummary: Pan-JAK inhibitor
-   A4520 R8-T198wtSummary: Pim-1 kinase inhibitor A4520 R8-T198wtSummary: Pim-1 kinase inhibitor
-   A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor
-   A8338 NSC 748595 CitationTarget: STATSummary: Stat3 inhibitor A8338 NSC 748595 CitationTarget: STATSummary: Stat3 inhibitor
-   A3675 NVP-BSK805Summary: ATP-competitive JAK2 inhibitor A3675 NVP-BSK805Summary: ATP-competitive JAK2 inhibitor
-   A4519 PIM-1 Inhibitor 2Summary: Potent Pim-1 kinase inhibitor A4519 PIM-1 Inhibitor 2Summary: Potent Pim-1 kinase inhibitor
-   A1845 Canertinib (CI-1033)Summary: HER family tyrosine kinase inhibitor A1845 Canertinib (CI-1033)Summary: HER family tyrosine kinase inhibitor
-   A8317 Fludarabine Phosphate (Fludara)2 CitationTarget: STATSummary: Inhibits STAT1 activation and DNA synthesis A8317 Fludarabine Phosphate (Fludara)2 CitationTarget: STATSummary: Inhibits STAT1 activation and DNA synthesis
-   A3515 JANEX-1Summary: JAK3 inhibitor A3515 JANEX-1Summary: JAK3 inhibitor
-   A1835 Pelitinib (EKB-569)Summary: EGFR inhibitor,potent and irreversible A1835 Pelitinib (EKB-569)Summary: EGFR inhibitor,potent and irreversible
